Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein

Virus Research

Volumn 121, Issue 1, 2006, Pages 58-64

  Heo, Tae Hwe ^a   Lee, Song Mi ^a   Bartosch, Birke ^b   Cosset, François Loïc ^b   Kang, Chang Yuil ^a  

^a Seoul National University   (South Korea)

^b University Lyon i   (France)

Author keywords

CD81; E2; HCV; Hepatitis; Pseudo particle; SR B1

Indexed keywords

CD81 ANTIGEN; GLYCOPROTEIN E2; RECOMBINANT PROTEIN; SCAVENGER RECEPTOR BI;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS ADSORPTION; VIRUS INFECTIVITY; VIRUS VIRULENCE;

ANTIGENS, CD; CELL LINE, TUMOR; HEPACIVIRUS; HUMANS; PROTEIN BINDING; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; SCAVENGER RECEPTORS, CLASS B; SOLUBILITY; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 33745598789     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.04.002     Document Type: Article

References (30)

1. Agnello V., Abel G., Elfahal M., Knight G.B., and Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 12766-12771
2. Alter M.J. Epidemiology of hepatitis C. Hepatology 26 (1997) 62S-65S
3. Babitt J., Trigatti B., Rigotti A., Smart E.J., Anderson R.G., Xu S., and Krieger M. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J. Biol. Chem. 272 (1997) 13242-13249
4. Bartenschlager R., and Lohmann V. Replication of hepatitis C virus. J. Gen. Virol. 81 (2000) 1631-1648
5. Barth H., Schafer C., Adah M.I., Zhang F., Linhardt R.J., Toyoda H., Kinoshita-Toyoda A., Toida T., Van Kuppevelt T.H., Depla E., Von Weizsacker F., Blum H.E., and Baumert T.F. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278 (2003) 41003-41012
6. Bartosch B., Dubuisson J., and Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197 (2003) 633-642
7. Bartosch B., Vitelli A., Granier C., Goujon C., Dubuisson J., Pascale S., Scarselli E., Cortese R., Nicosia A., and Cosset F.L. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278 (2003) 41624-41630
8. Bergelson J.M., Chan M., Solomon K.R., St John N.F., Lin H., and Finberg R.W. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 6245-6248
9. Boucheix C., and Rubinstein E. Tetraspanins. Cell. Mol. Life. Sci. 58 (2001) 1189-1205
10. Cherukuri A., Shoham T., Sohn H.W., Levy S., Brooks S., Carter R., and Pierce S.K. The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts. J. Immunol. 172 (2004) 370-380
11. Claas C., Stipp C.S., and Hemler M.E. Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J. Biol. Chem. 276 (2001) 7974-7984
12. Empig C.J., and Goldsmith M.A. Association of the caveola vesicular system with cellular entry by filoviruses. J. Virol. 76 (2002) 5266-5270
13. Flint M., Logvinoff C., Rice C.M., and McKeating J.A. Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins. J. Virol. 78 (2004) 6875-6882
14. Gardner J.P., Durso R.J., Arrigale R.R., Donovan G.P., Maddon P.J., Dragic T., and Olson W.C. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 4498-4503
15. Heo T.H., Chang J.H., Lee J.W., Foung S.K., Dubuisson J., and Kang C.Y. Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoprotein. J. Immunol. 173 (2004) 446-455
16. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., and McKeating J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7271-7276
17. Levy S., Todd S.C., and Maecker H.T. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16 (1998) 89-109
18. Lozach P.Y., Lortat-Jacob H., De Lacroix De Lavalette A., Staropoli I., Foung S., Amara A., Houles C., Fieschi F., Schwartz O., Virelizier J.L., Arenzana-Seisdedos F., and Altmeyer R. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J. Biol. Chem. 278 (2003) 20358-20366
19. McKeating J.A., Zhang L.Q., Logvinoff C., Flint M., Zhang J., Yu J., Butera D., Ho D.D., Dustin L.B., Rice C.M., and Balfe P. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J. Virol. 78 (2004) 8496-8505
20. Norkin L.C., Anderson H.A., Wolfrom S.A., and Oppenheim A. Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J. Virol. 76 (2002) 5156-5166
21. Op De Beeck A., Voisset C., Bartosch B., Ciczora Y., Cocquerel L., Keck Z., Foung S., Cosset F.L., and Dubuisson J. Characterization of functional hepatitis C virus envelope glycoproteins. J. Virol. 78 (2004) 2994-3002
22. Petracca R., Falugi F., Galli G., Norais N., Rosa D., Campagnoli S., Burgio V., Di Stasio E., Giardina B., Houghton M., Abrignani S., and Grandi G. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol. 74 (2000) 4824-4830
23. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., and Abrignani S. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
24. Pohlmann S., Zhang J., Baribaud F., Chen Z., Leslie G.J., Lin G., Granelli-Piperno A., Doms R.W., Rice C.M., and McKeating J.A. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 77 (2003) 4070-4080
25. Reed K.E., and Rice C.M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242 (2000) 55-84
26. Rhainds D., and Brissette L. The role of scavenger receptor class B type I (SR-BI) in lipid trafficking defining the rules for lipid traders. Int. J. Biochem. Cell Biol. 36 (2004) 39-77
27. Scarselli E., Ansuini H., Cerino R., Roccasecca R.M., Acali S., Filocamo G., Traboni C., Nicosia A., Cortese R., and Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21 (2002) 5017-5025
28. van der Goot F.G., and Harder T. Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin. Immunol. 13 (2001) 89-97
29. Zaitseva M., Peden K., and Golding H. HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors. Biochim. Biophys. Acta 1614 (2003) 51-61
30. Zhang J., Randall G., Higginbottom A., Monk P., Rice C.M., and McKeating J.A. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 78 (2004) 1448-1455